logo
ResearchBunny Logo
NEK2 inhibition triggers anti-pancreatic cancer immunity by targeting PD-L1

Medicine and Health

NEK2 inhibition triggers anti-pancreatic cancer immunity by targeting PD-L1

X. Zhang, X. Huang, et al.

This groundbreaking study reveals how NEK2 kinase phosphorylates PD-L1, hindering the impact of PD-L1-targeted immunotherapy in pancreatic cancer. The authors discovered that inhibiting NEK2 improves lymphocyte infiltration and enhances the immune response, offering a novel strategy for advancing pancreatic cancer treatment.

00:00
Playback language: English
Citation Metrics
Citations
0
Influential Citations
0
Reference Count
0

Note: The citation metrics presented here have been sourced from Semantic Scholar and OpenAlex.

Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny